ORIGINAL ARTICLE
The epithelium specific cell cycle regulator 14-3-3sigma is required for preventing entry into mitosis following ultraviolet B
Sandra Vogel,
Thomas Herzinger,
Sandra Vogel
Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
Search for more papers by this authorCorresponding Author
Thomas Herzinger
Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
Correspondence:
Dr Thomas Herzinger, PD, Department of Dermatology and Allergy, Ludwig Maximilian University Munich, Frauenlobstr. 9-11, Munich 80337, Germany.
Tel: +49 89 5160 6054
Fax: +49 89 5160 6132
e-mail: [email protected].
Search for more papers by this authorSandra Vogel,
Thomas Herzinger,
Sandra Vogel
Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
Search for more papers by this authorCorresponding Author
Thomas Herzinger
Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
Correspondence:
Dr Thomas Herzinger, PD, Department of Dermatology and Allergy, Ludwig Maximilian University Munich, Frauenlobstr. 9-11, Munich 80337, Germany.
Tel: +49 89 5160 6054
Fax: +49 89 5160 6132
e-mail: [email protected].
Search for more papers by this authorConflicts of interest:
None declared.
Summary
Background
Deoxyribonucleic acid damage activates cell cycle checkpoints in order to maintain genomic stability. We assessed the role of different checkpoint genes in response to ultraviolet B irradiation.
Methods
Cell lines expressing a dominant negative mutant of ataxia telangiectasia and Rad3 related (Atr) protein or overexpressing Cdc25A, cells deficient for 14-3-3σ, Nijmegen breakage syndrome (Nbs), or Ataxia telangiectasia mutated (Atm) were treated with ultraviolet B (UVB) and harvested after 12 h, 24 h, or 48 h for analysis by flow cytometry.
Results
Functional loss of Atm, Atr, or Nbs did not result in a significant alteration of the cell cycle profile. Overexpression of Cdc25A led to a delayed arrest at the G1/S transition in response to low doses of UVB. Loss of 14-3-3σ, a negative cell cycle regulator and downstream target of p53, caused a transient arrest at the G2/M boundary.
Conclusions
Loss of 14-3-3σ sensitizes cells to UVB. After a transient cell cycle arrest, 14-3-3σ-deficient cells die by undergoing mitotic catastrophe. Cdc25A overexpression causes a delayed arrest in response to low doses of UVB. After higher doses, Cdc25A is no longer able to overrun the checkpoint. Atm, Atr, or Nbs are not essential for the checkpoint response to UVB, suggesting the existence of redundant signaling pathways.
References
- 1 Poehlmann A, Roessner A. Importance of DNA damage checkpoints in the pathogenesis of human cancers. Pathol Res Pract 2010; 206: 591–601.
- 2 Cliby WA, Roberts CJ, Cimprich KA et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J 1998; 17: 159–169.
- 3 Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432: 316–323.
- 4 Buscemi G, Perego P, Carenini N et al. Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene 2004; 23: 7691–7700.
- 5 Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421: 499–506.
- 6 Busino L, Donzelli M, Chiesa M et al. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 2003; 426: 87–91.
- 7 Zhao S, Weng YC, Yuan SS et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 2000; 405: 473–477.
- 8 Wu X, Ranganathan V, Weisman DS et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 2000; 405: 477–482.
- 9 Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003; 3: 931–943.
- 10 Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401: 616–620.
- 11 Kastan MB, Zhan Q, El-Deiry WS et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587–597.
- 12 Nghiem P, Park PK, Kim Y, Vaziri C, Schreiber SL. ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation. Proc Natl Acad Sci U S A 2001; 98: 9092–9097.
- 13 Yazdi PT, Wang Y, Zhao S, Patel N, Lee EYHP, Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Gene Dev 2002; 16: 571–582.
- 14 Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 2002; 30: 290–294.
- 15 Heffernan TP, Simpson DA, Frank AR et al. An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage. Mol Cell Biol 2002; 22: 8552–8561.
- 16 Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001; 410: 842–847.
- 17 Rosenstein BS, Mitchell DL. Action spectra for the induction of pyrimidine(6-4)pyrimidone photoproducts and cyclobutane pyrimidine dimers in normal human skin fibroblasts. Photochem Photobiol 1987; 45: 775–780.
- 18 Ley RD, Peak MJ, Lyon LL. Induction of pyrimidine dimers in epidermal DNA of hairless mice by UVB: an action spectrum. J Invest Dermatol 1983; 80: 188–191.
- 19 Petrocelli T, Slingerland J. UVB induced cell cycle checkpoints in an early stage human melanoma line, WM35. Oncogene 2000; 19: 4480–4490.
- 20 Petrocelli T, Poon R, Drucker DJ, Slingerland JM, Rosen CF. UVB radiation induces p21Cip1/WAF1 and mediates G1 and S phase checkpoints. Oncogene 1996; 12: 1387–1396.
- 21 Blomberg I, Hoffmann I. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol 1999; 19: 6183–6194.
- 22 Bunz F, Dutriaux A, Lengauer C et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497–1501.
- 23 Kraakman-van der Zwet M, Overkamp WJ, Friedl AA et al. Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts. Mutat Res 1999; 434: 17–27.
- 24 Ziv Y, Jaspers NG, Etkin S et al. Cellular and molecular characteristics of an immortalized ataxia-telangiectasia (group AB) cell line. Cancer Res 1989; 49: 2495–2501.
- 25 Herzinger T, Reed SI. Cyclin D3 is rate-limiting for the G1/S phase transition in fibroblasts. J Biol Chem 1998; 273: 14958–14961.
- 26 Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008; 9: 759–769.
- 27 Foray N, Priestley A, Alsbeih G et al. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int J Radiat Biol 1997; 72: 271–283.
- 28 Ziv Y, Bar-Shira A, Pecker I et al. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 1997; 15: 159–167.
- 29 Kaufmann WK, Paules RS. DNA damage and cell cycle checkpoints. FASEB J 1996; 10: 238–247.
- 30 Elledge SJ. Cell cycle checkpoints: preventing an identity crisis. Science 1996; 274: 1664–1672.
- 31 Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001; 15: 2177–2196.
- 32 Hirao A, Kong YY, Matsuoka S et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000; 287: 1824–1827.
- 33 Tibbetts RS, Cortez D, Brumbaugh KM et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 2000; 14: 2989–3002.
- 34 Lu YP, Lou YR, Peng QY, Xie JG, Nghiem P, Conney AH. Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice. Cancer Res 2008; 68: 2523–2529.
- 35 Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci U S A 1980; 77: 7315–7317.
- 36 Carney JP, Maser RS, Olivares H et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 1998; 93: 477–486.
- 37 Heffernan TP, Kawasumi M, Blasina A, Anderes K, Conney AH, ATR-Chk1 N. pathway inhibition promotes apoptosis after UV treatment in primary human keratinocytes: potential basis for the UV protective effects of caffeine. J Invest Dermatol 2009; 129: 1805–1815.
- 38 Jinno S, Suto K, Nagata A et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J 1994; 13: 1549–1556.
- 39 Hoffmann I, Draetta G, Karsenti E. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J 1994; 13: 4302–4310.
- 40 Draetta G, Eckstein J. Cdc25 protein phosphatases in cell proliferation. Biochim Biophys Acta 1997; 1332: M53–M63.
- 41 Gabrielli BG, Clark JM, McCormack AK, Ellem KA. Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis. Oncogene 1997; 15: 749–758.
- 42 Herzinger T, Funk JO, Hillmer K, Eick D, Wolf DA, Kind P. Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene 1995; 11: 2151–2156.
- 43 Mailand N, Falck J, Lukas C et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000; 288: 1425–1429.
- 44 Molinari M, Mercurio C, Dominguez J, Goubin F, Draetta GF. Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep 2000; 1: 71–79.
- 45 Sexl V, Diehl JA, Sherr CJ, Ashmun R, Beach D, Roussel MF. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene 1999; 18: 573–582.
- 46 Mailand N, Podtelejnikov AV, Groth A, Mann M, Bartek J, Lukas J. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J 2002; 21: 5911–5920.
- 47 Lindqvist A, Kallstrom H, Lundgren A, Barsoum E, Rosenthal CK. Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J Cell Biol 2005; 171: 35–45.
- 48 Donzelli M, Squatrito M, Ganoth D, Hershko A, Pagano M, Draetta GF. Dual mode of degradation of Cdc25 A phosphatase. EMBO J 2002; 21: 4875–4884.
- 49 Yaffe MB, Rittinger K, Volinia S et al. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 1997; 91: 961–971.
- 50 Aitken A. 14-3-3 proteins on the MAP. Trends Biochem Sci 1995; 20: 95–97.
- 51 Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000; 40: 617–647.
- 52 Hermeking H, Lengauer C, Polyak K et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1: 3–11.
- 53 Benzinger A, Muster N, Koch HB, Yates JR, 3rd. Hermeking H. Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 2005; 4: 785–795.
- 54 Graves PR, Lovly CM, Uy GL, Piwnica-Worms H. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene 2001; 20: 1839–1851.
- 55 Zeng Y, Piwnica-Worms H. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol Cell Biol 1999; 19: 7410–7419.
- 56 Sanchez Y, Wong C, Thoma RS et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997; 277: 1497–1501.
- 57 Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997; 277: 1501–1505.
- 58 Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 1998; 141: 875–885.
- 59 Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev 2000; 14: 1584–1588.
- 60 Hemmati PG, Normand G, Gillissen B, Wendt J, Dorken B, Daniel PT. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF. Oncogene 2008; 27: 6707–6719.
- 61 Bhonde MR, Hanski ML, Budczies J et al. DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis. J Biol Chem 2006; 281: 8675–8685.
- 62 Maga G, Villani G, Crespan E et al. 8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. Nature 2007; 447: 606–608.
- 63 de Laat A, Kroon ED, de Gruijl FR. Cell cycle effects and concomitant p53 expression in hairless murine skin after longwave UVA (365 nm) irradiation: a comparison with UVB irradiation. Photochem Photobiol 1997; 65: 730–735.
- 64 Heald R, McLoughlin M, McKeon F. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 1993; 74: 463–474.
- 65 Rocha S, Perkins ND. ARF the integrator: linking NF-kappaB, p53 and checkpoint kinases. Cell Cycle 2005; 4: 756–759.
- 66 Cleaver JE. Repair replication and degradation of bromouracil-substituted DNA in mammalian cells after irradiation with ultraviolet light. Biophys J 1968; 8: 775–791.
- 67 Gardner R, Putnam CW, Weinert T. RAD53, DUN1 and PDS1 define two parallel G2/M checkpoint pathways in budding yeast. EMBO J 1999; 18: 3173–3185.
Citing Literature
